Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Acorda Therapeutics Profit Margin 2006-2020 | ACOR

Current and historical gross margin, operating margin and net profit margin for Acorda Therapeutics (ACOR) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Acorda Therapeutics net profit margin as of March 31, 2020 is -138.66%.
  
Acorda Therapeutics Annual Profit Margins
Acorda Therapeutics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.031B $0.192B
Acorda Therapeutics, Inc. is a biotechnology company developing and commercializing neurology therapies for Parkinson's disease, migraine and multiple sclerosis. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA? (dalfampridine) Extended Release Tablets, 10 mg.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.669B 15.50
Bristol Myers Squibb (BMY) United States $134.562B 11.24
CSL (CSLLY) Australia $91.768B 0.00
Gilead Sciences (GILD) United States $88.910B 12.79
Vertex Pharmaceuticals (VRTX) United States $71.813B 40.07
Regeneron Pharmaceuticals (REGN) United States $71.339B 27.50
Illumina (ILMN) United States $57.871B 59.47
Biogen (BIIB) United States $43.707B 7.48
Moderna (MRNA) United States $29.126B 0.00
Seattle Genetics (SGEN) United States $28.722B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.736B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.061B 9.61
Genmab (GMAB) Denmark $23.061B 18.97
Genmab (GNMSF) Denmark $21.833B 64.82
Incyte (INCY) United States $21.726B 0.00
BioMarin Pharmaceutical (BMRN) United States $21.670B 157.67
BeiGene (BGNE) Cayman Islands $19.895B 0.00
BioNTech SE (BNTX) Germany $18.818B 0.00
Alnylam Pharmaceuticals (ALNY) United States $17.622B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.565B 70.47
Exact Sciences (EXAS) United States $13.957B 0.00
Galapagos (GLPG) Belgium $12.394B 36.46
Sarepta Therapeutics (SRPT) United States $12.223B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.788B 29.01
ARGENX SE-ADR (ARGX) Netherlands $10.887B 0.00
QIAGEN (QGEN) Netherlands $10.816B 31.45
Bio-Techne Corp (TECH) United States $10.584B 73.25
Immunomedics (IMMU) United States $10.192B 0.00
Novavax (NVAX) United States $9.109B 0.00
Repligen (RGEN) United States $8.219B 130.45
Guardant Health (GH) United States $7.994B 0.00
Ascendis Pharma (ASND) Denmark $7.808B 0.00
Exelixis (EXEL) United States $7.191B 25.22
ACADIA Pharmaceuticals (ACAD) United States $6.783B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.636B 205.59
Emergent Biosolutions (EBS) United States $6.490B 25.71
SWEDISH ORP BIO (BIOVF) Sweden $6.351B 15.80
Vir Biotechnology (VIR) United States $5.966B 0.00
Acceleron Pharma (XLRN) United States $5.715B 0.00
Mirati Therapeutics (MRTX) United States $5.414B 0.00
Adaptive Biotechnologies (ADPT) United States $5.160B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.100B 0.00
Reata Pharmaceuticals (RETA) United States $4.947B 0.00
Zai Lab (ZLAB) China $4.648B 0.00
MyoKardia (MYOK) United States $4.575B 0.00
MorphoSys AG (MOR) Germany $4.516B 35.03
NeoGenomics (NEO) United States $4.286B 1293.67
China Biologic Products (CBPO) China $4.196B 23.33
Global Blood Therapeutics (GBT) United States $4.190B 0.00
Blueprint Medicines (BPMC) United States $4.066B 0.00
Halozyme Therapeutics (HALO) United States $3.886B 0.00
Amicus Therapeutics (FOLD) United States $3.811B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.791B 0.00
Bluebird Bio (BLUE) United States $3.475B 0.00
Inovio Pharmaceuticals (INO) United States $3.212B 0.00
Arena Pharmaceuticals (ARNA) United States $3.202B 0.00
Alkermes (ALKS) Ireland $2.974B 62.33
Principia Biopharma (PRNB) United States $2.831B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.711B 0.00
Amarin (AMRN) Ireland $2.710B 0.00
Insmed (INSM) United States $2.702B 0.00
Sorrento Therapeutics (SRNE) United States $2.692B 0.00
Twist Bioscience (TWST) United States $2.553B 0.00
Fate Therapeutics (FATE) United States $2.534B 0.00
Denali Therapeutics (DNLI) United States $2.471B 0.00
PHARMA MAR SA (PHMMF) Spain $1.922B 0.00
Ligand Pharmaceuticals (LGND) United States $1.893B 64.09
UniQure (QURE) Netherlands $1.878B 0.00
Viela Bio (VIE) United States $1.839B 0.00
Mesoblast (MESO) Australia $1.805B 0.00
Editas Medicine (EDIT) United States $1.761B 0.00
I-Mab (IMAB) China $1.753B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.657B 0.00
Eidos Therapeutics (EIDX) United States $1.620B 0.00
Sangamo Therapeutics (SGMO) United States $1.612B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.567B 0.00
Zymeworks (ZYME) Canada $1.429B 0.00
Adverum Biotechnologies (ADVM) United States $1.416B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.374B 0.00
Revance Therapeutics (RVNC) United States $1.369B 0.00
Zealand Pharma (ZEAL) Denmark $1.366B 0.00
Mersana Therapeutics (MRSN) United States $1.361B 0.00
Intra-Cellular Therapies (ITCI) United States $1.354B 0.00
NGM Biopharmaceuticals (NGM) United States $1.310B 0.00
Cytokineticsorporated (CYTK) United States $1.310B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Coherus BioSciences (CHRS) United States $1.269B 8.86
REGENXBIO (RGNX) United States $1.257B 0.00
Epizyme (EPZM) United States $1.243B 0.00
Arvinas (ARVN) United States $1.193B 0.00
Alector (ALEC) United States $1.187B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.161B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.157B 0.00
Akcea Therapeutics (AKCA) United States $1.131B 0.00
Alcobra (ARCT) United States $1.126B 0.00
Compugen (CGEN) Israel $1.100B 0.00
NantKwest (NK) United States $1.090B 0.00
VBI Vaccines (VBIV) United States $1.013B 0.00
Intellia Therapeutics (NTLA) United States $1.007B 0.00
Beam Therapeutics (BEAM) United States $0.999B 0.00
Retrophin (RTRX) United States $0.987B 0.00
Arcus Biosciences (RCUS) United States $0.967B 0.00
Heska (HSKA) United States $0.939B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Athenex (ATNX) United States $0.917B 0.00
Myriad Genetics (MYGN) United States $0.915B 47.19
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.873B 0.00
Dynavax Technologies (DVAX) United States $0.831B 0.00
Cara Therapeutics (CARA) United States $0.806B 0.00
Intrexon (PGEN) United States $0.796B 0.00
Vericel (VCEL) United States $0.759B 140.17
Pharming Group (PHGUF) Netherlands $0.739B 16.86
Cellectis S.A (CLLS) France $0.733B 0.00
Codexis (CDXS) United States $0.723B 0.00
Castle Biosciences (CSTL) United States $0.712B 0.00
Morphic Holding (MORF) United States $0.705B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.684B 0.00
Frequency Therapeutics (FREQ) United States $0.673B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.661B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
MiMedx (MDXG) United States $0.629B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Kadmon Holdings (KDMN) United States $0.592B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.591B 5.06
Agenus (AGEN) United States $0.578B 0.00
Cue Biopharma (CUE) United States $0.546B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.537B 0.00
Athersys (ATHX) United States $0.522B 0.00
IBio (IBIO) United States $0.520B 0.00
Kala Pharmaceuticals (KALA) United States $0.509B 0.00
Prothena (PRTA) Ireland $0.501B 0.00
Syros Pharmaceuticals (SYRS) United States $0.496B 0.00
AnaptysBio (ANAB) United States $0.493B 0.00
MeiraGTx Holdings (MGTX) United States $0.490B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.489B 0.00
Clovis Oncology (CLVS) United States $0.481B 0.00
AC Immune SA (ACIU) Switzerland $0.476B 0.00
Innate Pharma S.A (IPHA) France $0.475B 0.00
Anika Therapeutics (ANIK) United States $0.471B 20.58
UROGEN PHARMA (URGN) United States $0.464B 0.00
Cel-Sci (CVM) United States $0.453B 0.00
Protagonist Therapeutics (PTGX) United States $0.443B 0.00
BioDelivery Sciences (BDSI) United States $0.427B 22.42
Puma Biotechnology (PBYI) United States $0.425B 0.00
Avid Bioservices (CDMO) United States $0.424B 0.00
Prometic Life Sciences (LMNL) Canada $0.416B 0.00
Kamada (KMDA) Israel $0.394B 16.41
Xenon Pharmaceuticals (XENE) Canada $0.393B 0.00
PDL BioPharma (PDLI) United States $0.392B 344.00
Aquinox Pharmaceuticals (NLTX) United States $0.392B 0.00
Merus (MRUS) Netherlands $0.391B 0.00
ANI Pharmaceuticals (ANIP) United States $0.380B 7.40
Scholar Rock Holding (SRRK) United States $0.379B 0.00
Albireo Pharma (ALBO) United States $0.371B 0.00
MannKind (MNKD) United States $0.354B 0.00
Geron (GERN) United States $0.352B 0.00
Precision BioSciences (DTIL) United States $0.350B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.343B 0.00
CytomX Therapeutics (CTMX) United States $0.334B 0.00
WAVE Life Sciences (WVE) Singapore $0.321B 0.00
Seres Therapeutics (MCRB) United States $0.320B 0.00
ChromaDex (CDXC) United States $0.314B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.305B 0.00
Trevena (TRVN) United States $0.300B 0.00
Menlo Therapeutics (MNLO) United States $0.297B 0.00
OSMOTICA PHARM (OSMT) United States $0.293B 0.00
ADMA Biologics Inc (ADMA) United States $0.291B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.289B 0.00
Affimed (AFMD) Germany $0.285B 0.00
Starpharma Holdings (SPHRY) Australia $0.276B 0.00
Spero Therapeutics (SPRO) United States $0.275B 0.00
Cellular Biomedicine (CBMG) United States $0.263B 0.00
NextCure (NXTC) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.260B 0.00
Pluristem Therapeutics (PSTI) Israel $0.259B 0.00
Arbutus Biopharma (ABUS) United States $0.259B 0.00
DBV Technologies S.A (DBVT) France $0.257B 0.00
Celldex Therapeutics (CLDX) United States $0.252B 0.00
Pfenex (PFNX) United States $0.251B 0.00
Dyadic (DYAI) United States $0.247B 0.00
Abeona Therapeutics (ABEO) United States $0.244B 0.00
Verastem (VSTM) United States $0.241B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.235B 0.00
Fortress Biotech (FBIO) United States $0.232B 0.00
Selecta Biosciences (SELB) United States $0.229B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Five Prime Therapeutics (FPRX) United States $0.222B 0.00
IVERIC Bio (ISEE) United States $0.221B 0.00
Strongbridge Biopharma (SBBP) United States $0.220B 0.00
Aduro Biotech (ADRO) United States $0.216B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.210B 9.80
Exicure (XCUR) United States $0.203B 0.00
GENFIT S.A (GNFT) France $0.200B 0.00
Sutro Biopharma (STRO) United States $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Aptinyx (APTX) United States $0.189B 0.00
Theratechnologies (THTX) Canada $0.188B 0.00
XOMA (XOMA) United States $0.187B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aytu Bioscience (AYTU) United States $0.172B 0.00
Cerecor (CERC) United States $0.171B 0.00
VTv Therapeutics (VTVT) United States $0.169B 0.00
Bellus Health (BLU) Canada $0.164B 0.00
Liquidia Technologies (LQDA) United States $0.161B 0.00
Cidara Therapeutics (CDTX) United States $0.160B 0.00
TELA Bio (TELA) United States $0.151B 0.00
VolitionRX (VNRX) United States $0.146B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.142B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Kindred Biosciences (KIN) United States $0.140B 0.00
Cyclerion Therapeutics (CYCN) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Palatin Technologies (PTN) United States $0.131B 3.37
Lineage Cell Therapeutics (LCTX) United States $0.127B 0.00
Checkpoint Therapeutics (CKPT) United States $0.126B 0.00
Biofrontera AG (BFRA) Germany $0.126B 0.00
Cardiff Oncology (CRDF) United States $0.124B 0.00
Gritstone Oncology (GRTS) United States $0.123B 0.00
Oncobiologics (OTLK) United States $0.121B 0.00
Cocrystal Pharma (COCP) United States $0.120B 0.00
Orgenesis (ORGS) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
PHASEBIO PHARMA (PHAS) United States $0.118B 0.00
Windtree Therapeutics (WINT) United States $0.118B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.111B 0.00
Vaccinex (VCNX) United States $0.111B 0.00
CorMedix Inc (CRMD) United States $0.111B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
ARAVIVE, INC (ARAV) United States $0.094B 0.00
Organovo Holdings (ONVO) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Proteostasis Therapeutics (PTI) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.091B 0.00
Unum Therapeutics (UMRX) United States $0.089B 0.00
DiaMedica Therapeutics (DMAC) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.076B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Stealth BioTherapeutics (MITO) United States $0.073B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.069B 0.00
AnPac Bio-Medical Science (ANPC) China $0.068B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
Soligenix (SNGX) United States $0.063B 0.00
Edesa Biotech (EDSA) Canada $0.063B 0.00
Happiness Biotech Group (HAPP) China $0.061B 0.00
Signal Genetics (MGEN) United States $0.061B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Prana Biotechnology (ATHE) Australia $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Celsion (CLSN) United States $0.042B 0.00
Spherix (AIKI) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Genetic Technologies (GENE) Australia $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
OvaScience (MLND) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.032B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.030B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.018B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00